AstraZeneca teams up with Sputnik V vaccine/ Главная / Russkiy Mir Foundation / News / AstraZeneca teams up with Sputnik V vaccine
AstraZeneca teams up with Sputnik V vaccine
Photo credit: mos.ru / Y. Ivanko
Developers of the Russian Sputnik V vaccine will cooperate with the pharmaceutical company AstraZeneca, the Gazeta.ru news website writes. The representatives of the Russian company said that the Anglo-Swedish firm accepted their offer.
According to Alexander Gintsburg, who heads the Gamalei Center, AstraZeneca's vaccine is not effective enough. But this drawback can be corrected by adding another component contained in Sputnik V.
AstraZeneca believes that the combination of different vaccines could be an important milestone in the development of coronavirus prevention tools. It is planned that the tests will begin in December, volunteers over 18 years old will become their participants.
According to preliminary results of clinical trials of the AstraZeneca vaccine, its average efficacy reaches 70%. These data are based on the results of vaccination of 20,000 people living in the UK and Brazil.